Valuation : Attana AB

Market Cap 7.74M 799K 688K 652K 591K 1.11M 76.33M 1.11M 2.98M 38.83M 3M 2.93M 123M P/E 2024
-0.31x
P/E 2025 -1.11x
Enterprise Value 7.6M 784K 675K 640K 580K 1.09M 74.9M 1.09M 2.92M 38.11M 2.94M 2.88M 120M EV / Sales 2024
0.57x
EV / Sales 2025 5x
Free-Float
6.54%
Yield 2024 *
-
Yield 2025 -
Current month+50.00%
3 months-25.00%
6 months-62.50%
Current year-66.67%
1 week 0
Extreme 0.003
0
1 month 0
Extreme 0.002
0
Current year 0
Extreme 0.002
0.01
1 year 0
Extreme 0.002
0.02
3 years 0
Extreme 0.002
0.27
5 years 0
Extreme 0.002
1.16
10 years 0
Extreme 0.002
2.4
Manager TitleAgeSince
Chief Executive Officer - 31/03/2025
Chief Executive Officer 56 31/08/2002
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member 56 05/08/2012
Chairman 63 30/09/2015
Director/Board Member 62 31/12/2017
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-83.33%-98.64% 799K
-9.17%-3.62% - - 1.22B
-0.65%0.00%-34.15%-39.95% 666M
+11.79%+23.23%+87.43% - 405M
-0.76%-4.88%-43.23%-37.03% 122M
-2.26%-3.89%-30.80%+12.34% 66.68M
Average -0.18%-2.39%-20.82%-40.82% 414.34M
Weighted average by Cap. -2.87%-8.30%+4.20%-35.51%

Financials

2024 2025
Net sales 6.61M 683K 588K 557K 505K 947K 65.21M 952K 2.54M 33.17M 2.56M 2.51M 105M 4.01M 414K 356K 337K 306K 574K 39.52M 577K 1.54M 20.1M 1.55M 1.52M 63.53M
Net income -12.78M -1.32M -1.14M -1.08M -975K -1.83M -126M -1.84M -4.91M -64.09M -4.95M -4.84M -203M -10.5M -1.08M -934K -884K -801K -1.5M -104M -1.51M -4.04M -52.68M -4.07M -3.98M -166M
Net Debt 1.17M 121K 104K 98.59K 89.36K 168K 11.55M 169K 450K 5.87M 454K 444K 18.56M -145K -15.01K -12.93K -12.25K -11.1K -20.82K -1.43M -20.93K -55.93K -730K -56.37K -55.13K -2.31M
Logo Attana AB
Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attana’s biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Employees
6
Date Price Change Volume
11/09/26 SEK 0.003000 0.00% 23,023,433
10/09/26 SEK 0.003000 0.00% 30,304,730
09/09/26 SEK 0.003000 0.00% 3,493,135
08/09/26 SEK 0.003000 0.00% 21,483,057
07/09/26 SEK 0.003000 0.00% 1,315,708
  1. Stock Market
  2. Stocks
  3. ATANA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!